(thirdQuint)Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers.

 Treatment regimen 1: Fenobam [1-(3-chlorophenyl)-3-(1-methyl-4-oxo-2-imidazolidinylidine) urea hydrate], oral administration of one 50 mg gelatin capsule.

 Treatment regimen 2: Fenobam, oral administration of one 100 mg gelatin capsule.

 Treatment regimen 3: Fenobam, oral administration of one 150 mg gelatin capsule.

 Treatment regimen 4: Placebo (lactose), oral administration of one 150 mg gelatin capsule.

.

 Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers@highlight

This is a randomized, blinded, parallel group, placebo-controlled trial on 32 evaluable healthy male and non-pregnant female, 18-50 year old volunteers.

 The investigators goal is to observe the pharmacokinetics of fenobam after oral administration of 50, 100 or 150 mg in groups of healthy individuals and to compare the side effects and tolerability of a single dose of fenobam with placebo.

